formaldehyde has been researched along with Respiratory Syncytial Virus Infections in 34 studies
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy
Respiratory Syncytial Virus Infections: Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.
Excerpt | Relevance | Reference |
---|---|---|
" We evaluated the impact of TLR and Notch signaling on ERD in a murine model by administering CpG, an agonist of TLR9, in combination with L685,458, an inhibitor of Notch signaling during FI-RSV immunization." | 1.46 | CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells in Lung ( Deng, Y; Du, X; Hai, Y; Li, H; Li, N; Li, W; Wei, L; Yin, W; Zeng, R; Zhang, L; Zhang, Z; Zheng, B, 2017) |
" A dose-response relationship to vaccine dose was observed for ELISA, neutralizing and antifusion antibodies." | 1.29 | Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon. ( Ambrose, MW; Castleman, WL; Hildreth, SW; Jewell, AM; Piedra, PA; Speelman, DJ; Wyde, PR, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (20.59) | 18.2507 |
2000's | 14 (41.18) | 29.6817 |
2010's | 11 (32.35) | 24.3611 |
2020's | 2 (5.88) | 2.80 |
Authors | Studies |
---|---|
Lin, M | 2 |
Zhang, W | 2 |
Yin, YF | 1 |
Si, JY | 2 |
Zhang, LJ | 2 |
Chen, L | 2 |
Lin, X | 2 |
Wang, YB | 2 |
Zhang, J | 1 |
Zheng, ZZ | 2 |
Xia, NS | 2 |
Chen, F | 1 |
Park, HR | 1 |
Ji, HJ | 1 |
Kwon, Y | 1 |
Kim, MK | 1 |
Song, JY | 1 |
Ahn, KB | 1 |
Seo, HS | 1 |
Yin, W | 2 |
Li, HY | 1 |
Zheng, BY | 1 |
Deng, YQ | 1 |
Li, WJ | 1 |
Liu, Y | 1 |
Zeng, RH | 1 |
Zhan, LT | 1 |
Zhao, M | 1 |
Wu, GH | 1 |
Sun, YP | 1 |
Yu, C | 1 |
Fang, MJ | 1 |
Derscheid, RJ | 1 |
Gallup, JM | 1 |
Knudson, CJ | 1 |
Varga, SM | 2 |
Grosz, DD | 1 |
van Geelen, A | 1 |
Hostetter, SJ | 1 |
Ackermann, MR | 1 |
Rey, GU | 1 |
Miao, C | 1 |
Caidi, H | 1 |
Trivedi, SU | 1 |
Harcourt, JL | 1 |
Tripp, RA | 2 |
Anderson, LJ | 3 |
Haynes, LM | 1 |
Srinivasa, BT | 1 |
Fixman, ED | 1 |
Ward, BJ | 1 |
Lee, JS | 2 |
Cho, MK | 1 |
Hwang, HS | 3 |
Ko, EJ | 2 |
Lee, YN | 3 |
Kwon, YM | 2 |
Kim, MC | 3 |
Kim, KH | 2 |
Lee, YT | 3 |
Jung, YJ | 2 |
Kang, SM | 3 |
Moore, ML | 1 |
Lee, Y | 1 |
Sawada, A | 1 |
Nakayama, T | 1 |
Muralidharan, A | 1 |
Li, C | 1 |
Wang, L | 1 |
Li, X | 1 |
Zhang, L | 1 |
Li, H | 1 |
Hai, Y | 1 |
Li, W | 1 |
Zheng, B | 1 |
Du, X | 1 |
Li, N | 1 |
Zhang, Z | 1 |
Deng, Y | 1 |
Zeng, R | 1 |
Wei, L | 1 |
De Swart, RL | 1 |
Kuiken, T | 1 |
Timmerman, HH | 1 |
van Amerongen, G | 1 |
Van Den Hoogen, BG | 1 |
Vos, HW | 1 |
Neijens, HJ | 1 |
Andeweg, AC | 1 |
Osterhaus, AD | 1 |
Johnson, TR | 2 |
Parker, RA | 1 |
Johnson, JE | 1 |
Graham, BS | 3 |
Plotnicky, H | 1 |
Siegrist, CA | 1 |
Aubry, JP | 1 |
Bonnefoy, JY | 1 |
Corvaïa, N | 1 |
Nguyen, TN | 1 |
Power, UF | 1 |
Braciale, TJ | 1 |
Delgado, MF | 1 |
Polack, FP | 1 |
Oumouna, M | 2 |
Mapletoft, JW | 2 |
Karvonen, BC | 1 |
Babiuk, LA | 2 |
van Drunen Littel-van den Hurk, S | 2 |
Kalina, WV | 1 |
Woolums, AR | 2 |
Gershwin, LJ | 2 |
Townsend, HG | 1 |
Gomis, S | 1 |
Moghaddam, A | 1 |
Olszewska, W | 1 |
Wang, B | 1 |
Tregoning, JS | 1 |
Helson, R | 1 |
Sattentau, QJ | 1 |
Openshaw, PJ | 1 |
Piedra, PA | 1 |
Wyde, PR | 1 |
Castleman, WL | 1 |
Ambrose, MW | 1 |
Jewell, AM | 1 |
Speelman, DJ | 1 |
Hildreth, SW | 1 |
Connors, M | 1 |
Giese, NA | 1 |
Kulkarni, AB | 1 |
Firestone, CY | 1 |
Morse, HC | 1 |
Murphy, BR | 1 |
Waris, ME | 1 |
Tsou, C | 1 |
Erdman, DD | 1 |
Zaki, SR | 1 |
Wright, C | 1 |
Oliver, KC | 1 |
Fenwick, FI | 1 |
Smith, NM | 1 |
Toms, GL | 1 |
West, K | 1 |
Petrie, L | 1 |
Haines, DM | 1 |
Konoby, C | 1 |
Clark, EG | 1 |
Martin, K | 1 |
Ellis, JA | 1 |
Singer, RS | 1 |
Boyle, GA | 1 |
Peebles, RS | 1 |
Sheller, JR | 1 |
Collins, RD | 1 |
Jarzecka, K | 1 |
Mitchell, DB | 1 |
Boelen, A | 1 |
Andeweg, A | 1 |
Kwakkel, J | 1 |
Lokhorst, W | 1 |
Bestebroer, T | 1 |
Dormans, J | 1 |
Kimman, T | 1 |
Prince, GA | 2 |
Denamur, F | 1 |
Deschamps, M | 1 |
Garçon, N | 1 |
Prieels, JP | 1 |
Slaoui, M | 1 |
Thiriart, C | 1 |
Porter, DD | 2 |
Ponnuraj, EM | 1 |
Hayward, AR | 1 |
Raj, A | 1 |
Wilson, H | 1 |
Simoes, EAF | 1 |
Curtis, SJ | 1 |
Yim, KC | 1 |
2 reviews available for formaldehyde and Respiratory Syncytial Virus Infections
Article | Year |
---|---|
Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies.
Topics: Animals; Disease Models, Animal; Formaldehyde; Humans; Respiratory Syncytial Virus Infections; Respi | 2017 |
Involvement of antibody, complement and cellular immunity in the pathogenesis of enhanced respiratory syncytial virus disease.
Topics: Animals; Antibody Formation; Bronchopneumonia; Complement Activation; Disease Models, Animal; Formal | 2004 |
1 trial available for formaldehyde and Respiratory Syncytial Virus Infections
Article | Year |
---|---|
The effect of formalin-inactivated vaccine on respiratory disease associated with bovine respiratory syncytial virus infection in calves.
Topics: Animals; Antibodies, Viral; Cattle; Cattle Diseases; Cytotoxicity, Immunologic; Female; Formaldehyde | 1999 |
31 other studies available for formaldehyde and Respiratory Syncytial Virus Infections
Article | Year |
---|---|
An Optimized FI-RSV Vaccine Effectively Protects Cotton Rats and BALB/c Mice without Causing Enhanced Respiratory Disease.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Neutralizing; Antibodies, Viral; Formaldehyde; Lung; Mi | 2022 |
Gamma Irradiation-Inactivated Respiratory Syncytial Virus Vaccine Provides Protection but Exacerbates Pulmonary Inflammation by Switching from Prefusion to Postfusion F Protein.
Topics: Animals; Antibodies, Viral; Formaldehyde; Lung; Mice; Pneumonia; Reactive Oxygen Species; Respirator | 2023 |
Lipopolysaccharide Inhibits FI-RSV Vaccine-enhanced Inflammation Through Regulating Th Responses.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Female; Formaldehyde; Interleukin-17; Interleuki | 2019 |
The Optimal Concentration of Formaldehyde is Key to Stabilizing the Pre-Fusion Conformation of Respiratory Syncytial Virus Fusion Protein.
Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Cell Line; Disease Models, Animal; Epitopes; F | 2019 |
Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV.
Topics: Animals; Animals, Newborn; Antigens, Viral; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Fo | 2013 |
Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice.
Topics: Amino Acid Sequence; Animals; Antibodies, Viral; Formaldehyde; Immunization; Lung; Mice; Mice, Inbre | 2013 |
Inhibition of STAT6 during vaccination with formalin-inactivated RSV prevents induction of Th2-cell-biased airway disease.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line; Cytokines; Eosinophils; | 2014 |
Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses.
Topics: Animals; Female; Formaldehyde; Hep G2 Cells; Humans; Immunization; Immunoglobulin G; Immunomodulatio | 2014 |
Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease.
Topics: Administration, Intranasal; Animals; Antibodies, Neutralizing; Antibodies, Viral; Epitopes; Formalde | 2015 |
Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection.
Topics: Adaptive Immunity; Animals; CD4-Positive T-Lymphocytes; Clodronic Acid; Dendritic Cells; Eosinophils | 2015 |
Experimental animal model for analyzing immunobiological responses following vaccination with formalin-inactivated respiratory syncytial virus.
Topics: Animals; Antibodies, Viral; Cytokines; Formaldehyde; Lung; Measles virus; Models, Animal; Palivizuma | 2016 |
CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells in Lung
Topics: Adjuvants, Immunologic; Animals; Bronchial Hyperreactivity; Carbamates; CD8-Positive T-Lymphocytes; | 2017 |
Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection.
Topics: Animals; Animals, Newborn; Asthma; Bronchial Hyperreactivity; Formaldehyde; Humans; Immunization; In | 2002 |
IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.
Topics: Animals; Antibodies, Viral; Antibody Specificity; Cell Line; Cytokines; Formaldehyde; HN Protein; Hu | 2003 |
Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate.
Topics: Animals; Animals, Newborn; Antibodies, Viral; CD4-Positive T-Lymphocytes; Enzyme-Linked Immunosorben | 2003 |
Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV.
Topics: Animals; Formaldehyde; Immunization; Mice; Mice, Inbred BALB C; Pulmonary Eosinophilia; Receptors, A | 2004 |
Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine.
Topics: Adjuvants, Immunologic; Animals; Cell Line; Chemistry, Pharmaceutical; Formaldehyde; Immunization; I | 2005 |
Formalin-inactivated bovine RSV vaccine influences antibody levels in bronchoalveolar lavage fluid and disease outcome in experimentally infected calves.
Topics: Animals; Antibodies, Viral; Antibody Formation; Bronchoalveolar Lavage; Cattle; Cattle Diseases; For | 2005 |
Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus.
Topics: Adjuvants, Immunologic; Animals; Animals, Suckling; Antibodies, Viral; Cattle; Chemistry, Pharmaceut | 2006 |
A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines.
Topics: Animals; Antigens, Viral; Bronchoalveolar Lavage Fluid; Eosinophilia; Formaldehyde; Immunization; In | 2006 |
Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon.
Topics: Animals; Antibodies, Viral; Antibody Formation; Antigens, Viral; Chlorocebus aethiops; Epitopes; For | 1993 |
Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.
Topics: Animals; Formaldehyde; Immunization; Interferon-gamma; Interleukin-10; Interleukin-2; Interleukin-4; | 1994 |
Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern.
Topics: Animals; Base Sequence; Bronchoalveolar Lavage Fluid; CD4 Lymphocyte Count; Cytokines; DNA Primers; | 1996 |
A monoclonal antibody pool for routine immunohistochemical detection of human respiratory syncytial virus antigens in formalin-fixed, paraffin-embedded tissue.
Topics: Antibodies, Monoclonal; Antigens, Viral; Ascitic Fluid; Bronchiolitis, Viral; Formaldehyde; Humans; | 1997 |
Cytotoxic T-lymphocyte precursor frequencies in BALB/c mice after acute respiratory syncytial virus (RSV) infection or immunization with a formalin-inactivated RSV vaccine.
Topics: Animals; Bronchoalveolar Lavage Fluid; Female; Formaldehyde; Histocompatibility Antigens Class I; Hi | 1998 |
Interferon gamma production during bovine respiratory syncytial virus (BRSV) infection is diminished in calves vaccinated with formalin-inactivated BRSV.
Topics: Animals; Cattle; Cattle Diseases; Enzyme-Linked Immunosorbent Assay; Formaldehyde; Interferon-gamma; | 1999 |
Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV.
Topics: Administration, Intranasal; Animals; Disease Models, Animal; Female; Formaldehyde; Methacholine Chlo | 2000 |
Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice.
Topics: Animals; Antibodies, Viral; Child, Preschool; Cytokines; Female; Formaldehyde; Humans; Immunization; | 2000 |
Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease.
Topics: Adjuvants, Immunologic; Animals; Child; Female; Formaldehyde; Humans; Lipid A; Male; Pulmonary Alveo | 2001 |
Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine.
Topics: Animals; Disease Models, Animal; Formaldehyde; Humans; Inflammation; Lung; Macaca radiata; Respirato | 2001 |
Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine.
Topics: Animals; Autopsy; Bronchiolitis; Disease Models, Animal; Female; Formaldehyde; Humans; Lung; Male; P | 2001 |